GE, Global Good Licensing Deal with Access Bio Brings Asymptomatic Malaria Rapid Diagnostic Tests to Market
Intellectual Ventures' Global Good Fund and GE (NYSE:GE), have signed a licensing agreement with the diagnostics technology company Access Bio (KOSDAQ:950130) to manufacture and distribute innovative diagnostic technologies that will help global health workers to more rapidly identify asymptomatic malaria in low-resource regions around the world.